Inovio Pharmaceuticals
INO
#8897
Rank
ยฃ0.10 B
Marketcap
ยฃ1.55
Share price
2.48%
Change (1 day)
-50.68%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -ยฃ2.15

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ2.16. In 2024 the company made an earnings per share (EPS) of -ยฃ2.97 an increase over its 2023 EPS that were of -ยฃ4.57.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.15-27.44%
2024-ยฃ2.97-35.14%
2023-ยฃ4.57-56.62%
2022-ยฃ10.54-19.54%
2021-ยฃ13.1035.9%
2020-ยฃ9.64-11.57%
2019-ยฃ10.9015.24%
2018-ยฃ9.46-2.78%
2017-ยฃ9.736.93%
2016-ยฃ9.10134.88%
2015-ยฃ3.87-29.51%
2014-ยฃ5.49-57.34%
2013-ยฃ12.88146.55%
2012-ยฃ5.2220.83%
2011-ยฃ4.32-29.41%
2010-ยฃ6.13-48.48%
2009-ยฃ11.8910%
2008-ยฃ10.8111.11%
2007-ยฃ9.73-41.3%
2006-ยฃ16.57-66.91%
2005-ยฃ50.08110.61%
2004-ยฃ23.78-61.63%
2003-ยฃ61.97186.67%
2002-ยฃ21.62
2001N/A-100%
2000-ยฃ17.29-63.64%
1999-ยฃ47.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.29-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.84-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.94-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.52-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.70-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ2.70-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ4.89-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA